U.S. Orthopedic Reconstruction Devices Market: $21.44B

Market Outlook

By 2035, the U.S. Orthopedic Reconstruction Devices Market is expected to reach approximately USD 21.44 billion, expanding at a CAGR of 6.38% during the forecast period 2026-2035. The market was valued at USD 11.55 billion in 2025, with historical analysis from 2021 to 2024. Values in this report are expressed in USD billions. The market definition covers implantable and procedure-enabling systems used for hip, knee, shoulder, elbow, ankle, and small-joint reconstruction, including primary and revision implants, fixation components, robotic and navigation platforms, patient-specific planning, and selected connected technologies directly tied to reconstructive procedures. Spine systems, standalone trauma fixation, arthroscopy-only products, and general orthobiologics are excluded.

The U.S. orthopedic reconstruction devices industry is a high-value, procedure-driven segment built around the treatment of osteoarthritis, inflammatory joint disease, osteonecrosis, post-traumatic degeneration, congenital deformity, failed prior implants, and complex joint destruction. Demand is supported by a large pool of patients who have exhausted conservative treatment and require durable restoration of pain relief, mobility, and function. Diagnosed arthritis affected 21.3% of U.S. adults in 2024, while the population aged 65 and older reached 61.2 million and represented 18.0% of the national population. These demographic and disease indicators create a long-duration demand base for primary arthroplasty, revision reconstruction, fracture-related replacement, and increasingly personalized implant solutions.

The market is moving beyond conventional cobalt-chromium implants and manual instrumentation toward a connected reconstruction ecosystem. Robotic arm assistance, compact robotic platforms, imageless navigation, CT-based planning, mixed-reality visualization, patient-specific guides, additive manufacturing, cementless fixation, porous metal structures, dual-mobility constructs, smart implants, and digitally supported recovery pathways are changing how hospitals evaluate reconstruction technologies. The commercial value of an implant franchise is increasingly linked to the surrounding workflow platform: planning software, instrumentation efficiency, data capture, surgeon training, service support, and the ability to improve operating-room predictability.

The historical market expanded from approximately USD 8.35 billion in 2021 to USD 10.62 billion in 2024. Growth was supported by recovery of deferred elective procedures, normalization of hospital staffing, strong demand for knee and hip replacement, rising adoption of cementless fixation, expansion of robotic-assisted arthroplasty, and improved availability of implants and instrument sets. In 2025, the market reached USD 11.55 billion as procedure volumes remained resilient, ambulatory reconstruction programs expanded, and manufacturers increased commercial investment in digital orthopedics, shoulder robotics, revision systems, and outpatient-compatible technology.

The forecast is intentionally stronger than a mature implant-only outlook because the value pool is broadening. Procedure growth remains important, but the market is also benefiting from premium mix, robotic and navigation pull-through, revision complexity, extremity reconstruction, implant personalization, and hospital investment in episode economics. The most attractive suppliers will be those that can protect implant share while extending revenue across planning, capital equipment, disposable accessories, data services, and post-operative outcome management.

Introduction

According to the U.S. Orthopedic Reconstruction Devices Market Report, the market is shaped by a combination of advanced surgical infrastructure, high specialist density, broad insurance coverage, strong patient demand for restored mobility, and a competitive medtech environment that rapidly commercializes new implant and digital surgery technologies. Joint reconstruction is clinically important because it converts severe pain and functional limitation into measurable improvements in mobility, independence, and quality of life. It is economically important because hip, knee, and shoulder replacement service lines support operating-room utilization, imaging, rehabilitation, post-acute care, and long-term follow-up across the U.S. healthcare system.

The American Joint Replacement Registry is the world’s largest national hip and knee registry by annual procedural count and now contains data on more than five million procedures from hospitals, ambulatory surgery centers, and private practice groups across all 50 states, the District of Columbia, and Puerto Rico. This scale indicates both the maturity of U.S. arthroplasty and the growing importance of outcomes benchmarking. Registry participation, patient-reported outcomes, implant survivorship data, and revision signals increasingly influence product evaluation, surgeon choice, payer policy, and hospital quality strategy.

The U.S. orthopedic reconstruction devices market is not a uniform implant category. Knee and hip systems provide the largest recurring revenue base, while shoulder, ankle, elbow, and small-joint reconstruction contribute faster growth from lower penetration levels. Primary procedures generate the majority of volume, but revision cases create disproportionate value because they require specialized implants, augments, cones, stems, extraction tools, infection-management strategies, longer operating time, and higher inventory complexity. This mix gives the market both stable procedural demand and premium opportunities in complex reconstruction.

Hospital procurement is shifting from surgeon-specific implant preference toward service-line economics, without eliminating the influence of the surgeon. Value analysis committees increasingly examine implant cost, instrument burden, sterilization cycles, tray count, turnover time, robotics utilization, readmissions, discharge destination, revision risk, and the economics of the full episode. Vendors that can reduce the number of trays, support same-day discharge, standardize workflows across multiple facilities, and provide reliable local technical support are more likely to secure system-wide agreements.

From 2026 to 2035, the central strategic theme will be the integration of implants with precision execution and longitudinal evidence. Reconstruction companies will compete on the ability to identify the right patient, plan the procedure, reproduce alignment and soft-tissue targets, choose fixation appropriate to bone quality, document outcomes, and support recovery outside the hospital. The market will therefore reward platform depth more than isolated implant innovation. Companies that remain limited to commoditized components will face pricing pressure, while suppliers with differentiated workflows and evidence-supported ecosystems will have stronger pricing durability.

Key Market Drivers: What’s Fueling the U.S. Orthopedic Reconstruction Devices Market Boom?

The first major driver is the scale of arthritis and degenerative joint disease. More than one in five U.S. adults had diagnosed arthritis in 2024, and arthritis prevalence rises sharply with age. Osteoarthritis remains the principal clinical pathway into knee, hip, and selected shoulder replacement because progressive cartilage loss causes pain, stiffness, deformity, and functional decline. The volume opportunity is not limited to older retirees. Obesity, prior sports injury, occupational loading, and longer life expectancy are increasing the number of patients who require reconstruction during their working years and may later need revision surgery.

A second driver is population aging. The U.S. population aged 65 and older reached 61.2 million in 2024 and grew materially faster than the working-age population between 2020 and 2024. By 2030, all baby boomers will be older than 65. This demographic shift is particularly important for joint reconstruction because the incidence of symptomatic osteoarthritis, fragility fractures, rotator cuff arthropathy, and prior implant failure increases with age. Aging also expands the pool of medically complex patients who benefit from less invasive techniques, shorter anesthesia time, cementless or hybrid fixation options, and coordinated post-discharge recovery.

A third driver is the migration of appropriate hip and knee procedures toward hospital outpatient departments and ambulatory surgery centers. Total knee and total hip arthroplasty are no longer treated exclusively as inpatient procedures. Enhanced recovery protocols, regional anesthesia, blood-loss management, patient selection, home-based rehabilitation, and digital follow-up have made same-day or short-stay reconstruction feasible for a broader population. This shift creates demand for compact capital equipment, lower instrument burden, rapid room setup, reliable logistics, and implants designed for efficient reproducible workflows. It also expands access to commercially insured and younger patients who prefer outpatient recovery.

A fourth driver is the rapid adoption of robotic-assisted and digitally planned arthroplasty. Robotic systems help surgeons execute planned bone cuts, component positioning, limb alignment, and soft-tissue balancing with greater consistency. Hospitals invest in these platforms to support physician recruitment, patient acquisition, service-line differentiation, implant standardization, and marketing of advanced orthopedic capability. The economic case is strongest when a system supports multiple procedures, achieves high utilization, reduces variability, and is linked to a broad implant portfolio. The installed base also reinforces recurring implant pull-through and creates switching barriers.

A fifth driver is the expansion of cementless fixation and porous implant technologies. Improved porous coatings, additive manufacturing, bone-preserving designs, and instrument accuracy are supporting cementless adoption in younger and more active patients, particularly in total knee and hip reconstruction. Cementless fixation can reduce cement-related workflow steps and may offer durable biological fixation in appropriately selected patients. Its commercial impact is larger than unit growth alone because cementless systems often carry premium pricing and are closely associated with robotic planning, modern implant designs, and surgeon conversion programs.

A sixth driver is the increasing revision burden. As primary arthroplasty volumes grow and patients receive implants at younger ages, the cumulative number of patients living with joint replacements rises. Even low annual failure rates create substantial revision demand over time. Revisions are required for infection, loosening, instability, wear, fracture, malposition, and soft-tissue failure. These procedures are more complex than primary replacement and require specialized cones, sleeves, augments, stems, constrained liners, extraction tools, custom implants, and high-touch technical support. Revision reconstruction therefore represents a smaller volume segment but a high-value strategic category.

A seventh driver is payment reform and episode accountability. CMS’s planned CJR-X model is designed to make most eligible hospitals responsible for the cost and quality of hip, knee, and ankle replacement episodes through 90 days after discharge, beginning nationwide in October 2027. The earlier CJR model generated estimated net savings while maintaining quality. This direction increases the importance of implants and workflows that can support lower complications, home discharge, reduced post-acute utilization, fewer readmissions, and reliable patient-reported outcomes. Device suppliers will increasingly need to provide economic evidence alongside clinical evidence.

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. orthopedic reconstruction devices market is increasingly focused on precision, personalization, fixation durability, workflow simplification, and evidence generation. The next competitive cycle is not defined by a single new bearing material or component geometry. It is defined by the interaction between implant design, preoperative planning, intraoperative execution, instrument efficiency, data capture, and recovery management. Manufacturers are raising the bar by developing systems that make complex decisions more reproducible while reducing avoidable variation across surgeons and care settings.

Robotic-assisted surgery is the most visible innovation area. Large robotic-arm platforms have established the category in total knee, partial knee, and total hip replacement, while compact and handheld systems are broadening access for hospitals and ASCs with different capital budgets and space constraints. Competition is moving toward multi-application platforms that can support knee, hip, shoulder, spine, or other procedures from a common capital base. The long-term commercial advantage will depend on utilization, clinical evidence, user experience, service reliability, and the breadth of compatible implants rather than robotic novelty alone.

Shoulder reconstruction is entering a new phase of digital and robotic adoption. Reverse shoulder arthroplasty has expanded because it addresses rotator cuff-deficient shoulders and complex anatomy, while preoperative 3D planning has become increasingly important for glenoid positioning, version correction, bone preservation, and implant selection. FDA-cleared robotic shoulder platforms and expanded planning services are moving shoulder reconstruction closer to the precision ecosystem already established in knee and hip procedures. This segment is expected to produce above-market growth because current penetration remains lower and the clinical complexity supports premium workflow tools.

Additive manufacturing is improving the design of porous surfaces, patient-matched components, metaphyseal cones, augments, and complex revision implants. Three-dimensional printing allows manufacturers to create structures that would be difficult to produce through conventional machining and can improve bone integration or fit in severe bone loss. In routine primary reconstruction, additive manufacturing supports cementless components and efficient product iteration. In complex revision or oncology-related reconstruction, it enables custom solutions that may preserve bone and avoid more radical surgery.

Implant materials and articulation strategies are also advancing. Highly cross-linked polyethylene, vitamin E-stabilized liners, ceramic heads, oxidized zirconium surfaces, titanium nitride coatings, dual-mobility constructs, and improved porous titanium are being used to address wear, stability, metal sensitivity, and fixation. In hip reconstruction, dual mobility is increasingly relevant for instability risk and revision cases. In knee reconstruction, manufacturers are differentiating through kinematic design, constraint options, cementless fixation, and compatibility with robotic planning. In shoulder reconstruction, convertible platforms and glenoid-side options are central to inventory and revision strategy.

Smart implants and connected recovery systems represent an emerging layer. Sensors embedded in implants or associated wearable platforms can capture gait, range of motion, activity, or recovery signals. Although smart implant revenue remains small relative to conventional implant sales, connected data can help identify delayed recovery, support remote care, and generate real-world evidence. The commercial challenge is to integrate data into clinical workflow without creating monitoring burden. Platforms that provide actionable alerts, patient engagement, and payer-relevant outcomes are more likely to gain sustained adoption.

Manufacturers are also innovating in instrument efficiency. Orthopedic reconstruction requires large inventories, loaner logistics, sterilization capacity, and trained operating-room staff. Reduced-tray systems, sterile-packed instruments, automated impactors, disposable cutting guides, and simplified workflows can reduce setup time and sterilization burden. These operational improvements may be less visible than robotics but are highly relevant to ASCs and high-volume hospitals where room turnover, staffing, and central sterile processing capacity directly affect profitability.

Clinical evidence is becoming a competitive capability. Health systems increasingly expect registry data, implant survivorship, complication rates, patient-reported outcomes, learning-curve analysis, and health-economic models. Claims of improved precision are no longer sufficient unless they can be connected to meaningful outcomes or operational gains. Suppliers that can combine product registries, robotic data, real-world evidence, and episode-cost analysis will be better positioned in value-based procurement and payer discussions.

Segmentation Insights

The U.S. Orthopedic Reconstruction Devices Market is segmented on the basis of product category, procedure type, technology type, end user, and region. The segmentation reflects how U.S. buyers organize reconstructive service lines and how manufacturers capture value through implants, enabling platforms, and procedural support.

By Product Category

Knee Reconstruction Devices

Knee reconstruction devices represent the largest product category, accounting for an estimated 45.5% of market value in 2025, or approximately USD 5.26 billion. The segment includes total knee systems, unicompartmental knee systems, patellofemoral implants, revision knees, stems, cones, sleeves, augments, tibial and femoral components, polyethylene inserts, and procedure-specific instrumentation. Demand is supported by the high prevalence of knee osteoarthritis, obesity-related joint loading, strong patient awareness, and a large base of surgeons trained in total knee arthroplasty. Growth is shifting toward cementless fixation, robotic-assisted balancing, personalized alignment philosophies, revision constructs, and outpatient workflows. Knee reconstruction will remain the largest category through 2035, although faster growth in shoulder and ankle systems will modestly reduce its share.

Hip Reconstruction Devices

Hip reconstruction devices accounted for an estimated 33.0% of the 2025 market, or approximately USD 3.81 billion. The category includes acetabular cups, femoral stems, modular heads, liners, dual-mobility components, hemiarthroplasty systems, resurfacing systems, revision shells, augments, cages, and specialized extraction tools. U.S. growth is supported by osteoarthritis, femoral neck fractures, osteonecrosis, younger active patients, and revision demand. Direct anterior approach adoption, robotic cup placement, dual-mobility use, cementless stems, and efficient short-stay pathways are important commercial themes. Hip replacement is a mature category, but premium mix and revision complexity support durable value growth.

Shoulder and Elbow Reconstruction Devices

Shoulder and elbow reconstruction devices generated an estimated USD 1.33 billion in 2025 and represent one of the fastest-growing categories. Products include anatomic and reverse shoulder systems, glenoid components, humeral stems and stemless implants, fracture platforms, revision components, elbow replacement systems, and digital planning tools. Reverse shoulder arthroplasty is the primary growth engine because it can address rotator cuff arthropathy, complex fractures, failed prior surgery, and selected revision cases. Robotic shoulder systems, CT-based planning, augmented glenoids, convertible platforms, and patient-specific guides are expected to support a CAGR above the market average through 2035.

Foot and Ankle Reconstruction Devices

Foot and ankle reconstruction devices represented approximately USD 0.69 billion in 2025. The segment includes total ankle replacement systems, first metatarsophalangeal joint implants, hindfoot and midfoot reconstruction systems, patient-specific cutting guides, and selected small-joint solutions. Total ankle replacement is gaining attention as implant designs, instrumentation, and surgeon training improve, offering motion preservation for selected patients with end-stage ankle arthritis. The market remains concentrated in specialist centers, but new FDA-cleared systems, stronger clinical education, and increasing patient demand for mobility-preserving procedures are expanding adoption.

Small-Joint, Custom and Complex Reconstruction Systems

Small-joint, custom, and complex reconstruction systems accounted for approximately USD 0.46 billion in 2025. This segment includes wrist, finger, thumb, toe, custom pelvic, oncologic, and severe bone-loss reconstruction solutions, along with patient-matched implants and specialized revision components. Volumes are lower than knee and hip, but average selling prices can be high because cases require advanced planning, unique manufacturing, and extensive surgeon support. Additive manufacturing and digital design are expanding the addressable market by making complex reconstruction more clinically practical and commercially scalable.

By Procedure Type

Primary Total Joint Replacement

Primary total joint replacement is the dominant procedure type and represented an estimated 70% of market revenue in 2025. Total knee and total hip arthroplasty account for most procedures, while total and reverse shoulder replacement are growing quickly. Primary procedures benefit from standardized care pathways, large implant portfolios, established reimbursement, and increasing outpatient eligibility. Commercial competition is intense because hospitals can use high primary volumes to negotiate pricing, but premium fixation, robotics, planning, and differentiated bearing options allow manufacturers to defend value.

Partial, Unicompartmental and Resurfacing Procedures

Partial and bone-preserving procedures include unicompartmental knee replacement, patellofemoral replacement, selected hip resurfacing, stemless shoulder arthroplasty, and focal small-joint reconstruction. These procedures address patients with localized disease or anatomy suitable for preservation of healthy bone and soft tissue. Robotic assistance can improve consistency in partial knee replacement, while advanced planning supports stemless and resurfacing procedures. The segment is smaller than total replacement but strategically important because it aligns with earlier intervention and active-patient expectations.

Revision Reconstruction

Revision reconstruction is expected to record one of the strongest value growth rates. Revision procedures require removal of failed components, management of infection or bone loss, restoration of stability, and reconstruction around compromised anatomy. High-value products include cones, sleeves, modular stems, constrained or hinged knees, revision shells, cages, augments, dual-mobility liners, custom components, and specialized extraction tools. Suppliers with deep revision portfolios, rapid logistics, and experienced technical support have an advantage because implant availability and intraoperative flexibility are critical.

Fracture-Related Arthroplasty

Fracture-related arthroplasty includes hip hemiarthroplasty or total hip replacement for femoral neck fractures, reverse shoulder arthroplasty for selected proximal humerus fractures, and replacement solutions used when fixation is unlikely to succeed. Demand is strongly linked to the aging population, osteoporosis, fall risk, and hospital trauma volume. These cases are often urgent rather than elective, making inventory availability, surgeon familiarity, and broad sizing options essential. The segment also carries significant episode-cost implications because patients may require longer stays and post-acute care.

Complex and Patient-Specific Reconstruction

Complex and patient-specific reconstruction includes severe deformity, major bone loss, oncologic resection, failed multiple revisions, congenital abnormalities, and unusual anatomy. Digital design, 3D printing, custom augments, and patient-specific instruments can improve fit and enable limb-sparing solutions. The commercial model differs from standard arthroplasty because lead times, case planning, engineering collaboration, and regulatory controls are more intensive. Growth will be strong from a small base as advanced academic centers and regional referral hospitals adopt more personalized solutions.

By Technology Type

Conventional Manual Implant Systems

Conventional manual systems remain the largest technology category by value because most U.S. reconstructions still rely on standard implants and mechanical instruments. Their strengths are broad surgeon familiarity, lower capital requirements, flexible implant choice, and established clinical evidence. Competition is based on implant design, fixation options, inventory availability, instrument efficiency, contracting, and local service. Manual systems will continue to grow in absolute value, but their share will decline as robotic and digitally planned procedures expand.

Robotic-Assisted Reconstruction

Robotic-assisted reconstruction is the fastest-growing technology category. Systems range from large robotic-arm platforms to compact handheld devices and are used across partial knee, total knee, total hip, and increasingly shoulder replacement. Hospitals evaluate robotics through capital cost, service fees, disposables, implant pull-through, utilization, surgeon demand, and potential operational or clinical benefits. The winning platforms will be multi-procedure, easy to deploy, evidence-supported, and integrated with commercially competitive implant portfolios.

Navigation and Digital Planning

Navigation and digital planning include imageless navigation, CT-based planning, intraoperative alignment tools, 3D shoulder planning, fluoroscopic guidance, and software that supports component positioning or range-of-motion analysis. These technologies can provide a lower-capital pathway to precision surgery and may be especially attractive to ASCs or hospitals that do not need a full robotic platform. Their adoption depends on workflow simplicity, interoperability, accuracy, and whether the technology creates meaningful differentiation for surgeons and patients.

Patient-Specific and Additively Manufactured Technologies

Patient-specific guides, custom implants, 3D-printed porous structures, and anatomy-informed component designs are expanding across primary and revision reconstruction. These technologies support improved fit, bone preservation, and solutions for severe defects. Additive manufacturing is also enabling cementless fixation and rapid iteration of porous structures at scale. The segment will grow faster than the total market, although reimbursement, production lead time, and the need for case-specific planning will limit adoption to clinically justified use cases.

Smart Implants and Connected Recovery Platforms

Smart implants and connected recovery platforms remain emerging but strategically important. Sensor-enabled components, wearable activity tracking, digital patient engagement, remote range-of-motion assessment, and automated outcome collection can support earlier identification of recovery problems and stronger real-world evidence. Adoption will depend on integration with electronic health records, clinician workflow, privacy controls, and reimbursement or episode-management value. The most sustainable business models will link data to actionable care pathways rather than simply generating additional measurements.

By End User

Hospitals and Integrated Delivery Networks

Hospitals and integrated delivery networks are the dominant end users, accounting for an estimated 68% of 2025 market value. They perform the majority of complex primary, revision, fracture-related, and medically high-risk reconstruction procedures. Large systems negotiate enterprise implant contracts, standardize vendors, manage robotics across facilities, and use value analysis committees to evaluate new technology. Their priorities include predictable supply, surgeon coverage, instrument availability, sterilization efficiency, quality performance, and total episode economics. Manufacturers that can support multiple hospitals with consistent pricing and service are best positioned in this segment.

Ambulatory Surgery Centers

Ambulatory surgery centers represented an estimated 21% of market value in 2025 and are the fastest-growing end-user group. ASCs focus on selected low-risk patients, efficient scheduling, same-day discharge, and tightly managed implant cost. They favor compact or mobile technology, reduced tray count, simple setup, reliable vendor logistics, and implants with predictable workflows. Commercially insured knee, hip, and shoulder procedures create attractive economics, but growth depends on payer contracts, patient selection, anesthesia capability, and rapid access to escalation pathways when complications occur.

Orthopedic Specialty Hospitals and Joint Centers

Orthopedic specialty hospitals and dedicated joint centers are strategically important because they concentrate high procedure volume, standardized pathways, and subspecialist expertise. These facilities can achieve high robotics utilization, efficient turnover, and strong patient-reported outcome collection. They often act as reference sites for manufacturers and influence broader adoption through surgeon education. Procurement decisions are sophisticated and data-driven, with emphasis on implant survivorship, workflow consistency, instrument optimization, and the economics of high-throughput care.

Academic Medical Centers and Regional Referral Centers

Academic medical centers and regional referral hospitals are critical for revision, infection, oncologic, deformity, and complex reconstruction. They lead clinical trials, train fellows, generate registry evidence, and evaluate emerging robotic or custom technologies. Their cases require broad inventory, custom engineering, and advanced technical support. Although price scrutiny is significant, these centers are willing to adopt premium technology when it addresses unmet clinical need or enables procedures that cannot be completed with standard implants.

Orthopedic Clinics and Other Outpatient Providers

Orthopedic clinics and other outpatient providers influence reconstruction demand through diagnosis, conservative treatment, surgical referral, preoperative optimization, and post-operative monitoring. Most do not purchase major implant systems directly, but physician-owned practices may have equity relationships with ASCs or participate in implant selection and bundled care. Digital recovery, remote monitoring, imaging, and patient engagement tools are increasingly relevant to these users because they manage longitudinal outcomes outside the operating room.

Regional Insights: Where the Market is Growing Fastest

The U.S. Orthopedic Reconstruction Devices Market is geographically segmented into the Northeast, Midwest, South, and West. Regional performance differs based on population scale, age distribution, obesity and arthritis burden, hospital and ASC density, payer mix, orthopedic surgeon concentration, academic referral capacity, and adoption of robotic and digital technologies. The South was the largest regional market in 2025, while the West is expected to record the fastest CAGR through 2035. The Northeast remains the most evidence-intensive and high-acuity region, and the Midwest provides a durable base of established arthroplasty demand and medtech expertise.

South

The South was the largest regional market, accounting for approximately USD 4.45 billion in 2025. The region includes Delaware, the District of Columbia, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, West Virginia, Alabama, Kentucky, Mississippi, Tennessee, Arkansas, Louisiana, Oklahoma, and Texas. Its leadership is supported by the largest regional population base, rapid growth in major metropolitan areas, substantial arthritis and obesity burden, expanding Medicare demand, and continued investment in orthopedic hospitals, ASCs, and robotic surgery programs.

Texas and Florida are the two most important state markets in the South. Texas combines large patient pools with high-volume orthopedic networks in Houston, Dallas-Fort Worth, Austin, and San Antonio. Its commercial opportunity spans premium robotic platforms in major systems, outpatient arthroplasty in suburban markets, and scalable implant programs across regional hospitals. Florida has one of the country’s most favorable age profiles for joint replacement demand; by 2024, older adults outnumbered children in the state. Its large Medicare population supports hip, knee, shoulder, fracture-related, and revision procedures, while population migration sustains new capacity investment.

North Carolina, Georgia, Tennessee, and Virginia are high-growth markets because of population expansion, strong academic centers, and the development of orthopedic service lines beyond the largest cities. North Carolina benefits from major research and referral systems and a growing base of ASCs. Georgia’s Atlanta market supports advanced robotics, revision care, and surgeon training. Tennessee has a strong orthopedic provider and medical technology presence, while Virginia combines affluent suburban demand with academic and military-linked healthcare capacity.

Maryland, Delaware, and the District of Columbia form a high-value corridor with dense specialist networks and evidence-driven procurement, although Maryland hospitals may face different participation rules under federal episode models. South Carolina, Alabama, Mississippi, Louisiana, Arkansas, Kentucky, West Virginia, and Oklahoma have important unmet need associated with arthritis, obesity, rural access gaps, and limited availability of complex reconstruction outside major referral centers. These states create opportunity for hub-and-spoke referral models, mobile or compact enabling technology, and digital recovery support that reduces travel burden.

The South is projected to reach approximately USD 8.40 billion by 2035, representing a regional CAGR of about 6.56%. Growth will be led by outpatient knee and hip replacement, reverse shoulder arthroplasty, cementless fixation, robotic platform expansion, and revision volume. The region will remain highly competitive because large health systems can use their scale to negotiate pricing, making service reliability and workflow economics essential for suppliers.

West

The West represented approximately USD 2.37 billion in 2025 and is forecast to grow at the fastest regional CAGR, about 7.09%, reaching approximately USD 4.70 billion by 2035. The region includes California, Washington, Oregon, Nevada, Arizona, Idaho, Montana, Wyoming, Colorado, New Mexico, Utah, Alaska, and Hawaii. Its growth is supported by technology-oriented provider systems, strong ambulatory adoption, population expansion in the Mountain West, and close links between clinical practice, medtech development, digital health, and venture investment.

California is the largest state market in the West and one of the most influential reconstruction markets nationally. Major academic centers and integrated systems in Los Angeles, San Diego, the Bay Area, Sacramento, and Orange County are early adopters of robotic surgery, patient-specific planning, smart implants, and digital recovery. The state also has a large commercially insured population and a strong base of orthopedic technology companies. Procurement can be demanding because health systems expect evidence, interoperability, sustainability, and enterprise-scale service.

Arizona, Nevada, Colorado, and Utah are the highest-growth state opportunities. Arizona and Nevada combine rapid population growth with aging in-migration, creating strong demand for knee, hip, and shoulder replacement. Colorado supports premium technology adoption through integrated systems and an active patient population. Utah had the nation’s youngest median age in 2024, but its fast population growth, sports-related joint damage, and efficient provider networks support rising reconstruction demand across a broader age mix.

Washington and Oregon are attractive for digitally enabled, outcomes-focused models. Oregon was among the states where older adults outnumbered children in 2024, strengthening the long-term arthroplasty demand base. Washington combines high-income metropolitan markets with large integrated providers that can deploy technology across multiple sites. Idaho, Montana, Wyoming, New Mexico, Alaska, and Hawaii are smaller markets, but they create opportunities for regional referral centers, compact robotics, remote planning, and digital follow-up because geographic distance can limit access to subspecialty care. Montana and Hawaii also joined the group of states where older adults outnumbered children by 2024.

The West’s strategic importance extends beyond procedure volume. It is likely to lead adoption of connected recovery, AI-supported planning, mixed reality, and patient-specific manufacturing. However, suppliers must adapt to diverse market conditions, from high-cost coastal systems to fast-growing suburban ASCs and rural referral networks. Platforms that are modular and scalable will have the strongest regional fit.

Northeast

The Northeast accounted for approximately USD 2.83 billion in 2025 and is projected to reach approximately USD 4.95 billion by 2035, reflecting a CAGR of about 5.75%. The region includes Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York, and Pennsylvania. It has the highest regional median age, dense hospital infrastructure, strong academic medicine, and a high concentration of orthopedic subspecialists. These characteristics support premium reconstruction, complex revision, clinical research, and rigorous outcomes evaluation.

New York is the largest state market in the region, supported by high procedure volumes, major academic systems, large community networks, and a broad payer mix. New Jersey benefits from dense suburban demand, high commercial insurance coverage, and proximity to major device companies and surgeon education centers. Pennsylvania has a large and aging population, extensive health-system networks, and strong orthopedic programs in Philadelphia, Pittsburgh, and regional markets. Pennsylvania was among the states where older adults outnumbered children in 2024, reinforcing the long-term demand profile.

Massachusetts is disproportionately influential because of its academic hospitals, clinical research, engineering ecosystem, and early evaluation of robotics, digital planning, and custom implants. Connecticut and Rhode Island support high-value arthroplasty through dense provider networks and older populations. Maine had the oldest state median age in the country in 2024 at 44.8, while Vermont and New Hampshire also have aging profiles that support sustained hip, knee, shoulder, and fracture-related reconstruction demand despite smaller absolute populations.

The Northeast is especially important for revision reconstruction, periprosthetic joint infection management, complex shoulder procedures, and custom implants. Procurement committees often require strong clinical and economic evidence, and surgeon preference is balanced against enterprise contracting and quality goals. Growth is slower than in the South and West because population expansion is more limited and the market is mature, but per-procedure value remains high. Suppliers can succeed through evidence generation, reference-site partnerships, and specialized revision support rather than price competition alone.

Midwest

The Midwest represented approximately USD 1.90 billion in 2025 and is forecast to reach approximately USD 3.39 billion by 2035, growing at about 5.96% annually. The region includes Ohio, Indiana, Illinois, Michigan, Wisconsin, Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, and South Dakota. Demand is supported by established arthroplasty programs, high chronic disease burden in several states, broad community hospital networks, regional referral systems, and a deep orthopedic manufacturing and clinical expertise base.

Illinois, Ohio, Michigan, and Minnesota are the largest state markets. Chicago supports a broad mix of academic, community, and outpatient reconstruction programs. Ohio has nationally recognized orthopedic and hospital systems and significant hip, knee, shoulder, and revision capacity; the Cleveland metropolitan area was among the large metros where older adults outnumbered children by 2024. Michigan has durable demand associated with an aging population and large integrated systems. Minnesota is strategically important because of its medtech ecosystem, orthopedic innovation, and sophisticated value-analysis capabilities.

Indiana, Wisconsin, Missouri, Iowa, and Kansas provide stable procedure volumes across primary knee and hip replacement, fracture-related arthroplasty, and shoulder reconstruction. Indiana has a strong orthopedic manufacturing and surgeon network, while Wisconsin and Iowa benefit from integrated regional systems that can standardize implant platforms. Missouri’s major urban markets support complex reconstruction and training. Kansas combines metropolitan demand with rural referral needs.

Nebraska, North Dakota, and South Dakota are smaller in revenue but important for access-oriented models. Patients often travel to regional centers for complex reconstruction, making preoperative coordination and remote recovery particularly valuable. The Midwest generally adopts new technology after evidence and economic value are established, but once selected, systems can achieve durable share through long-term health-system relationships. Suppliers that offer reliable service, efficient contracting, and strong clinical education are well positioned in this region.

Key Market Players

The U.S. Orthopedic Reconstruction Devices Competitive Landscape is concentrated at the top, with Stryker, Zimmer Biomet, DePuy Synthes, and Smith+Nephew controlling a substantial share of knee and hip reconstruction and maintaining broad relationships with U.S. hospitals and surgeons. Enovis, Exactech, Globus Medical, Arthrex, Medacta, MicroPort, and other focused competitors add pressure in extremities, robotics, patient-specific solutions, and specialized implants. The market remains open to innovation because surgeons and health systems will adopt new technologies that solve a meaningful clinical or workflow problem, but commercial scale requires instrument inventory, field support, education, regulatory capability, and reliable supply.

Competition is increasingly platform-based. Large manufacturers bundle implants, robotics, navigation, planning software, service, and data tools across multiple joints. This model strengthens implant pull-through and creates switching costs. Mid-sized and specialist companies compete through differentiated anatomy, simpler instrumentation, custom implants, focused surgeon relationships, and faster product development. The most defensible positions combine differentiated technology with evidence, local technical support, and a clear economic case for hospitals and ASCs.

Some of the key players in the U.S. Orthopedic Reconstruction Devices industry are:

Stryker Corporation
Zimmer Biomet Holdings, Inc.
DePuy Synthes (Johnson & Johnson MedTech)
Smith+Nephew plc
Enovis Corporation, including DJO and LimaCorporate
Exactech, Inc.
Globus Medical, Inc.
Arthrex, Inc.
Medacta International
MicroPort Orthopedics
Corin Group
B. Braun Aesculap
restor3d, including Conformis
Shoulder Innovations, Inc.
Catalyst OrthoScience Inc.
THINK Surgical, Inc.
OrthAlign, Inc.
Materialise NV
United Orthopedic Corporation
Ortho Development Corporation
Waldemar LINK GmbH & Co. KG
Maxx Orthopedics, Inc.
Implantcast GmbH
Tyber Medical LLC

Stryker’s competitive strength is built around the Triathlon knee, hip reconstruction portfolio, Tornier shoulder franchise, and Mako SmartRobotics ecosystem. Zimmer Biomet combines Persona, ROSA, shoulder, hip, and extremity systems with a broad U.S. commercial footprint. DePuy Synthes competes through ATTUNE, VELYS, hip and shoulder platforms, revision solutions, and automated surgical tools. Smith+Nephew combines knee and hip implants with the CORI platform, shoulder planning, cementless technologies, and ambulatory-oriented workflows. Enovis has expanded its position through a broad extremities and reconstruction portfolio, while Exactech, Arthrex, restor3d, Shoulder Innovations, and Catalyst provide focused innovation in shoulder, custom reconstruction, and specialized implant design.

Market share through 2035 will be influenced by robotic installed base, implant pull-through, cementless adoption, shoulder growth, revision depth, ASC suitability, surgeon conversion capacity, field service, supply-chain reliability, regulatory execution, and real-world evidence. Companies that can demonstrate better episode economics and integrate patient-reported outcomes into procurement discussions will be better positioned to defend premium pricing. Conversely, suppliers with narrow portfolios, excessive tray burden, or inconsistent local support will face increasing pressure as health systems consolidate vendors.

Recent Developments

Recent developments in the U.S. Orthopedic Reconstruction Devices Market show a decisive shift toward multi-joint robotics, compact enabling technology, shoulder digitization, and portfolio restructuring. In March 2025, Stryker reported that more than 1.5 million Mako procedures had been performed globally across 45 countries while showcasing expansion across hip, knee, spine, and shoulder. By 2026, Mako Shoulder had entered full market release, integrating reverse shoulder implants, planning software, and robotic execution. This expands the commercial logic of robotics beyond the high-volume knee and hip base.

Zimmer Biomet received U.S. FDA clearance for ROSA Shoulder in 2024, positioning the system as the first robotic assistant for shoulder replacement. The company continued to expand shoulder capabilities and its robotics pipeline through 2025 and 2026, including miniature and semi-autonomous concepts. These developments intensify competition around multi-application robotics and demonstrate that shoulder reconstruction is becoming a strategic platform category rather than a niche implant business.

Johnson & Johnson MedTech introduced the KINCISE 2 automated surgical impactor in 2025 for primary and revision hip and knee procedures, adding cup-extraction capability for complex hip revision and targeting surgeon fatigue and workflow efficiency. The company also announced its intent in October 2025 to separate its orthopaedics business as a standalone DePuy Synthes company. The planned separation could create a more focused reconstruction competitor with independent capital allocation, while also increasing execution risk during the transition.

Smith+Nephew expanded its digital reconstruction offering with CORIOGRAPH preoperative planning and modeling services for total shoulder arthroplasty in the United States in 2025, complementing existing hip and knee solutions. Its 2025 performance also showed strong growth in other reconstruction revenue associated with the CORI Surgical System and consumables. The development supports a broader industry shift from implant-only selling toward integrated planning, enabling technology, and recurring procedural revenue.

Extremity reconstruction also advanced. Stryker launched the FDA-cleared Incompass Total Ankle System in September 2025 for end-stage ankle arthritis, highlighting growing manufacturer investment in motion-preserving ankle replacement. Across the market, new systems are emphasizing improved instrumentation, porous fixation, planning, and surgeon training to expand total ankle adoption beyond a limited specialist base.

Payment policy is becoming a market development in its own right. CMS finalized the CJR-X model as a nationwide mandatory episode-based payment test beginning October 1, 2027 for eligible hip, knee, and ankle replacements in inpatient and hospital outpatient settings. Hospitals will be evaluated against target prices covering the procedure and 90-day recovery period, with quality requirements tied to reconciliation. This policy direction is expected to increase demand for evidence that links implant and workflow choices to complications, discharge, rehabilitation use, patient-reported outcomes, and total episode cost.

Conclusion

The U.S. Orthopedic Reconstruction Devices Market Size & Share is positioned for sustained expansion from USD 11.55 billion in 2025 to approximately USD 21.44 billion by 2035, supported by a 6.38% CAGR during the forecast period. The market’s long-term strength is grounded in arthritis prevalence, rapid growth of the older population, high patient expectations for mobility, resilient joint replacement volumes, outpatient migration, revision demand, and the expansion of precision technologies around the implant.

Knee reconstruction will remain the largest revenue category, followed by hip, while shoulder, ankle, custom, and revision systems will generate disproportionate growth. Robotic-assisted surgery, cementless fixation, digital planning, additive manufacturing, smart recovery, and multi-joint platforms will shape competitive advantage. Conventional implants will continue to provide the majority of revenue, but value creation will increasingly come from the surrounding ecosystem of capital equipment, software, instruments, service, and outcomes data.

Regional opportunity will be led by the South because of population scale, migration, chronic disease burden, and rapid expansion of orthopedic capacity. The West will grow fastest because of technology adoption, Mountain West population growth, and digitally oriented provider systems. The Northeast will remain critical for complex reconstruction, evidence generation, and premium procedure value, while the Midwest will provide stable demand, medtech expertise, and durable health-system relationships. Texas, Florida, California, New York, Pennsylvania, New Jersey, Illinois, Ohio, Michigan, Minnesota, North Carolina, Georgia, Arizona, Colorado, and Massachusetts will remain especially important state markets.

For manufacturers, investors, distributors, and health systems, the central question is not whether joint reconstruction demand will expand. The more important questions are which platforms will convert precision into measurable outcomes, how fast outpatient and episode-based models will change procurement, where revision and extremity demand will concentrate, and which suppliers can scale service without eroding economics. Companies that combine differentiated implants, reliable execution, efficient instrumentation, strong clinical evidence, and episode-level value will define the next decade of the U.S. orthopedic reconstruction devices industry.

TABLE OF CONTENT

1. U.S. Orthopedic Reconstruction Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Orthopedic Reconstruction Implant Manufacturers
1.6.2. Robotic Surgery and Digital Orthopedic Technology Providers
1.6.3. Biomaterial, Component and Contract Manufacturing Suppliers
1.6.4. Hospitals and Integrated Delivery Networks
1.6.5. Orthopedic Specialty Hospitals and Joint Replacement Centers
1.6.6. Ambulatory Surgery Centers and Physician-Owned Facilities
1.6.7. Group Purchasing Organizations, Distributors and Specialty Suppliers
1.6.8. Orthopedic Surgeons, Clinical Societies and Registry Organizations
1.6.9. Commercial Payers, Medicare, Regulators and Value Analysis Committees

What this section provides: This section defines the market boundary, study scope, methodology, assumptions and stakeholder ecosystem so clients understand how the U.S. orthopedic reconstruction devices market is measured, segmented and validated.

2. U.S. Orthopedic Reconstruction Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size Opportunity, 2025–2035
2.8. High-Growth Product and Procedure Categories
2.9. Priority Technology and Investment Opportunities
2.10. Regional and State-Level Opportunity Summary

What this section provides: This section gives decision-makers a concise view of market size, growth direction, procedure demand, technology adoption, competitive intensity and the most commercially attractive opportunities through 2035.

3. U.S. Orthopedic Reconstruction Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising Osteoarthritis and Degenerative Joint Disease Burden
3.1.2. Aging U.S. Population and Expansion of Joint Replacement Eligibility
3.1.3. Increasing Hip, Knee and Shoulder Arthroplasty Volumes
3.1.4. Migration of Joint Replacement Procedures to Outpatient Settings
3.1.5. Expansion of Robotic-Assisted and Digitally Planned Reconstruction
3.1.6. Growing Adoption of Cementless and Bone-Preserving Implants
3.1.7. Rising Demand for Revision and Complex Reconstruction Procedures
3.1.8. Increasing Patient Expectations for Mobility and Functional Recovery
3.2. Restraints and Their Impact Analysis
3.2.1. High Implant, Robotic Platform and Procedure Costs
3.2.2. Hospital Pricing Pressure and Vendor Consolidation
3.2.3. Periprosthetic Joint Infection and Revision Risk
3.2.4. Product Recall, Implant Failure and Litigation Exposure
3.2.5. Reimbursement Pressure and Bundled-Payment Scrutiny
3.2.6. Orthopedic Surgeon and Skilled Operating-Room Workforce Constraints
3.3. Opportunities and Their Impact Analysis
3.3.1. Robotic-Assisted Hip, Knee and Shoulder Reconstruction
3.3.2. Cementless Knee and Hip Implant Adoption
3.3.3. Reverse Shoulder Arthroplasty Expansion
3.3.4. Total Ankle Replacement and Extremity Reconstruction
3.3.5. Patient-Specific and Additively Manufactured Implants
3.3.6. Smart Implants and Connected Recovery Platforms
3.3.7. Ambulatory Surgery Center-Oriented Implant Systems
3.3.8. Revision Arthroplasty and Complex Bone-Loss Solutions
3.4. Challenges and Their Impact Analysis
3.4.1. Demonstrating Clinical Value Beyond Implant Design
3.4.2. Achieving Adequate Robotic Platform Utilization
3.4.3. Managing Instrument Inventory and Sterilization Complexity
3.4.4. Standardizing Outcomes Across Hospitals and Ambulatory Centers
3.4.5. Maintaining Field-Service Coverage and Supply Reliability
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Joint Replacement Procedure Volume Analysis
3.7. Clinical Workflow Economics Analysis
3.8. Hospital Capital Procurement Behavior Analysis
3.9. Ambulatory Joint Replacement Economics Analysis
3.10. Implant Pricing and Total Episode Cost Analysis

What this section provides: This section explains the demographic, clinical, reimbursement, technological and operational forces shaping reconstruction demand, helping clients assess growth opportunities, commercial barriers and execution risks.

4. U.S. Orthopedic Reconstruction Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Hospital and ASC Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitution and Non-Surgical Treatment
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Implant Pricing Analysis by Joint Category
4.5. Value Chain & Supply Chain Analysis
4.6. Raw Material and Orthopedic Component Supply Analysis
4.7. Impact of Digitalization and Connected Orthopedic Care
4.8. Application & Innovation Landscape
4.9. Orthopedic Registry and Real-World Evidence Landscape
4.10. FDA Regulatory Framework Analysis
4.11. CMS Reimbursement and Coverage Landscape
4.12. Bundled-Payment and Episode-Based Care Analysis
4.13. Import/Export Restrictions & Tariff Impact
4.14. Government Initiatives and Musculoskeletal Health Programs
4.15. Impact of Escalating Geopolitical Tensions
4.16. Hospital Value Analysis Committee Decision Framework
4.17. Ambulatory Surgery Center Vendor Selection Framework
4.18. Sustainability, Reprocessing and Operating-Room Waste Considerations

What this section provides: This section gives clients a complete view of the external market environment, including regulation, reimbursement, pricing, supply chain, digital adoption, evidence requirements and hospital or ASC procurement dynamics.

5. U.S. Orthopedic Reconstruction Devices Market – By Product Type

5.1. Overview
5.1.1. Segment Share Analysis, By Product Type, 2025 & 2035 (%)
5.1.2. Knee Reconstruction Devices
5.1.2.1. Primary Total Knee Replacement Implants
5.1.2.2. Unicompartmental Knee Replacement Implants
5.1.2.3. Patellofemoral Reconstruction Systems
5.1.2.4. Revision Knee Replacement Systems
5.1.2.5. Femoral, Tibial and Patellar Components
5.1.2.6. Knee Reconstruction Instruments and Accessories
5.1.3. Hip Reconstruction Devices
5.1.3.1. Primary Total Hip Replacement Implants
5.1.3.2. Hip Hemiarthroplasty Systems
5.1.3.3. Hip Resurfacing Systems
5.1.3.4. Revision Hip Replacement Systems
5.1.3.5. Acetabular Components
5.1.3.6. Femoral Stems and Femoral Heads
5.1.3.7. Hip Reconstruction Instruments and Accessories
5.1.4. Shoulder Reconstruction Devices
5.1.4.1. Anatomic Total Shoulder Replacement Systems
5.1.4.2. Reverse Shoulder Replacement Systems
5.1.4.3. Shoulder Hemiarthroplasty Systems
5.1.4.4. Stemless Shoulder Implants
5.1.4.5. Revision Shoulder Reconstruction Systems
5.1.4.6. Glenoid, Humeral and Augmented Components
5.1.5. Foot and Ankle Reconstruction Devices
5.1.5.1. Total Ankle Replacement Systems
5.1.5.2. Ankle Revision Systems
5.1.5.3. Great-Toe and Small-Joint Replacement Implants
5.1.5.4. Patient-Specific Foot and Ankle Reconstruction Devices
5.1.6. Elbow and Small-Joint Reconstruction Devices
5.1.6.1. Total Elbow Replacement Systems
5.1.6.2. Radial Head Replacement Systems
5.1.6.3. Wrist Reconstruction Implants
5.1.6.4. Hand and Finger Joint Replacement Implants
5.1.6.5. Revision Elbow and Small-Joint Systems

What this section provides: This section identifies which orthopedic reconstruction product categories and subcategories are expected to generate the highest revenue contribution, procedure demand and growth through 2035.

6. U.S. Orthopedic Reconstruction Devices Market – By Clinical Application

6.1. Overview
6.1.1. Segment Share Analysis, By Clinical Application, 2025 & 2035 (%)
6.1.2. Osteoarthritis and Degenerative Joint Disease
6.1.2.1. Knee Osteoarthritis
6.1.2.2. Hip Osteoarthritis
6.1.2.3. Glenohumeral Osteoarthritis
6.1.2.4. Ankle and Small-Joint Osteoarthritis
6.1.3. Rheumatoid and Inflammatory Arthritis
6.1.3.1. Rheumatoid Arthritis
6.1.3.2. Psoriatic Arthritis
6.1.3.3. Other Inflammatory Joint Disorders
6.1.4. Trauma and Post-Traumatic Joint Reconstruction
6.1.4.1. Femoral Neck Fracture Reconstruction
6.1.4.2. Proximal Humerus Fracture Reconstruction
6.1.4.3. Post-Traumatic Knee and Ankle Arthritis
6.1.4.4. Complex Articular Injury Reconstruction
6.1.5. Osteonecrosis, Deformity and Congenital Joint Conditions
6.1.5.1. Femoral Head Osteonecrosis
6.1.5.2. Joint Dysplasia and Anatomical Deformity
6.1.5.3. Limb Alignment and Bone-Defect Reconstruction
6.1.6. Revision Arthroplasty and Implant Failure
6.1.6.1. Aseptic Loosening
6.1.6.2. Periprosthetic Joint Infection
6.1.6.3. Instability and Dislocation
6.1.6.4. Implant Wear and Mechanical Failure
6.1.6.5. Periprosthetic Fracture
6.1.6.6. Severe Bone-Loss Reconstruction

What this section provides: This section helps clients understand demand by clinical indication and prioritize applications with high procedure volumes, complex implant requirements, reimbursement relevance and unmet reconstruction needs.

7. U.S. Orthopedic Reconstruction Devices Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Hospitals and Integrated Delivery Networks
7.1.2.1. Large Multihospital Health Systems
7.1.2.2. Community and Regional Hospitals
7.1.2.3. Government and Veterans’ Healthcare Facilities
7.1.3. Ambulatory Surgery Centers
7.1.3.1. Independent Ambulatory Surgery Centers
7.1.3.2. Hospital-Owned Ambulatory Surgery Centers
7.1.3.3. Physician-Owned Joint Replacement Centers
7.1.4. Orthopedic Specialty Hospitals and Dedicated Joint Centers
7.1.4.1. Orthopedic Specialty Hospitals
7.1.4.2. High-Volume Joint Replacement Institutes
7.1.4.3. Sports Medicine and Reconstruction Centers
7.1.5. Academic Medical Centers and Regional Referral Centers
7.1.5.1. Teaching Hospitals
7.1.5.2. Complex Revision and Infection Centers
7.1.5.3. Orthopedic Research and Clinical Trial Centers
7.1.6. Orthopedic Clinics and Other Outpatient Providers
7.1.6.1. Multispecialty Orthopedic Practices
7.1.6.2. Preoperative Optimization Clinics
7.1.6.3. Post-Acute and Digital Recovery Providers

What this section provides: This section explains which care settings and customer groups are expected to drive implant purchasing, robotic adoption, outpatient procedure migration and recurring digital-recovery demand.

8. U.S. Orthopedic Reconstruction Devices Market – By Technology Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.1.2. Conventional Manual Implant Systems
8.1.2.1. Standard Mechanical Instrumentation
8.1.2.2. Conventional Cemented Implant Systems
8.1.2.3. Conventional Cementless Implant Systems
8.1.3. Robotic-Assisted Reconstruction Systems
8.1.3.1. Robotic-Arm Surgical Platforms
8.1.3.2. Handheld Robotic Systems
8.1.3.3. Autonomous and Semi-Autonomous Systems
8.1.3.4. Multijoint Robotic Platforms
8.1.4. Navigation and Digital Planning Technologies
8.1.4.1. Imageless Navigation
8.1.4.2. CT-Based Surgical Planning
8.1.4.3. Fluoroscopy-Assisted Navigation
8.1.4.4. Three-Dimensional Shoulder Planning
8.1.4.5. Intraoperative Alignment and Balancing Technologies
8.1.5. Patient-Specific and Additively Manufactured Technologies
8.1.5.1. Patient-Specific Instrumentation
8.1.5.2. Custom Reconstruction Implants
8.1.5.3. Three-Dimensional Printed Porous Implants
8.1.5.4. Custom Augments, Cones and Bone-Loss Solutions
8.1.6. Smart Implants and Connected Recovery Platforms
8.1.6.1. Sensor-Enabled Orthopedic Implants
8.1.6.2. Wearable Recovery Monitoring
8.1.6.3. Remote Range-of-Motion Assessment
8.1.6.4. Digital Patient Engagement Platforms
8.1.6.5. AI-Assisted Outcome and Risk Analytics

What this section provides: This section evaluates the technology platforms transforming orthopedic reconstruction, including robotics, digital planning, cementless fixation, additive manufacturing, patient-specific systems and connected recovery.

9. U.S. Orthopedic Reconstruction Devices Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct Hospital and Health System Procurement
9.1.2.1. Individual Hospital Contracts
9.1.2.2. Capital Equipment and Implant Agreements
9.1.2.3. Procedure-Based Pricing Arrangements
9.1.3. Integrated Delivery Network Enterprise Contracts
9.1.3.1. Multiyear Enterprise Agreements
9.1.3.2. Vendor Standardization Contracts
9.1.3.3. Robotic Platform and Implant Pull-Through Agreements
9.1.4. Group Purchasing Organization Contracts
9.1.4.1. National GPO Agreements
9.1.4.2. Regional Purchasing Alliances
9.1.4.3. Committed and Non-Committed Contracts
9.1.5. Distributor and Specialty Supplier Sales
9.1.5.1. Independent Orthopedic Distributors
9.1.5.2. Manufacturer-Owned Distribution Networks
9.1.5.3. Specialty Implant and Instrument Suppliers
9.1.6. Ambulatory and Physician-Owned Facility Procurement
9.1.6.1. Direct ASC Implant Contracts
9.1.6.2. Physician Preference-Based Purchasing
9.1.6.3. Bundled Implant and Enabling-Technology Agreements

What this section provides: This section helps clients understand how orthopedic reconstruction devices are purchased in the U.S., including enterprise contracting, GPO influence, robotic platform agreements, distributor relationships and ASC procurement behavior.

10. U.S. Orthopedic Reconstruction Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Joint Replacement Procedure Volume Analysis
10.1.4. Regional Hospital, Specialty Center and ASC Infrastructure Analysis
10.1.5. Regional Arthritis, Aging and Obesity Burden Analysis
10.1.6. Regional Reimbursement and Procurement Dynamics
10.1.7. Regional Robotic Surgery and Digital Technology Adoption

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Orthopedic Reconstruction Key Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Orthopedic Reconstruction Key Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Orthopedic Reconstruction Key Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Orthopedic Reconstruction Key Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level analysis, helping clients identify priority U.S. geographies, joint replacement hubs, outpatient migration markets, technology-adoption hotspots and state-level commercial opportunities.

11. U.S. Orthopedic Reconstruction Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Competitive Benchmarking by Product Portfolio
11.4. Competitive Benchmarking by Robotic and Digital Capabilities
11.5. Competitive Benchmarking by U.S. Distribution and Surgeon Support
11.6. Company Profiles

11.6.1. Stryker Corporation
11.6.2. Zimmer Biomet Holdings, Inc.
11.6.3. DePuy Synthes – Johnson & Johnson MedTech
11.6.4. Smith+Nephew plc
11.6.5. Enovis Corporation
11.6.6. Exactech, Inc.
11.6.7. Globus Medical, Inc.
11.6.8. Arthrex, Inc.
11.6.9. Medacta International
11.6.10. MicroPort Orthopedics
11.6.11. Corin Group
11.6.12. B. Braun Aesculap
11.6.13. restor3d, Inc.
11.6.14. Shoulder Innovations, Inc.
11.6.15. Catalyst OrthoScience Inc.
11.6.16. THINK Surgical, Inc.
11.6.17. OrthAlign, Inc.
11.6.18. Materialise NV
11.6.19. United Orthopedic Corporation
11.6.20. Ortho Development Corporation
11.6.21. Waldemar LINK GmbH & Co. KG
11.6.22. Maxx Orthopedics, Inc.
11.6.23. Implantcast GmbH
11.6.24. Tyber Medical LLC

Note: Each company profile will include company overview, orthopedic reconstruction portfolio, major implant platforms, robotic and digital capabilities, U.S. commercial strategy, financial positioning, clinical evidence, regulatory updates, partnerships, acquisitions and recent developments.

What this section provides: This section gives clients competitor benchmarking, market-share visibility, implant and technology portfolio positioning, innovation direction and strategic intelligence on leading orthopedic reconstruction companies.

12. U.S. Orthopedic Reconstruction Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Multijoint Robotic Reconstruction Platforms
12.2.2. AI-Assisted Surgical Planning and Component Positioning
12.2.3. Patient-Specific and Three-Dimensional Printed Implants
12.2.4. Smart Implants and Connected Recovery Platforms
12.2.5. Advanced Cementless Fixation and Porous Surface Technologies
12.2.6. Mixed-Reality and Augmented-Reality Surgical Guidance
12.2.7. Automated Orthopedic Instruments and Workflow Technologies
12.3. Emerging Business Trends
12.3.1. Shift from Implant Selling to Integrated Procedure Platforms
12.3.2. Expansion of Outpatient Hip, Knee and Shoulder Replacement
12.3.3. Growth of Risk-Sharing and Episode-Based Commercial Models
12.3.4. Increasing Use of Registry and Patient-Reported Outcome Data
12.3.5. Consolidation of Implant Vendors by Large Health Systems
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.6. Product-Technology Opportunity Matrix
12.7. Regional Expansion Opportunity Matrix
12.8. Market Entry and Partnership Opportunity Assessment

What this section provides: This section prepares clients for technology disruption, procedure migration, reimbursement changes, investment opportunities and potential market-development scenarios through 2035.

13. U.S. Orthopedic Reconstruction Devices Market: Strategic Recommendations

13.1. Recommendations for Orthopedic Implant Manufacturers
13.2. Recommendations for Robotic and Digital Surgery Companies
13.3. Recommendations for Hospitals and Integrated Delivery Networks
13.4. Recommendations for Orthopedic Specialty Hospitals and Joint Centers
13.5. Recommendations for Ambulatory Surgery Centers
13.6. Recommendations for Investors and Private Equity Firms
13.7. Recommendations for Distributors and Channel Partners
13.8. Recommendations for New Entrants and Startups
13.9. Go-to-Market Strategy Considerations
13.10. Surgeon Education and Conversion Strategy
13.11. Hospital Value Analysis and Economic Evidence Strategy
13.12. Product Positioning and Portfolio Expansion Guidance
13.13. ASC-Specific Commercialization Strategy
13.14. Regional and State-Level Market Expansion Strategy
13.15. Partnership, Licensing and Acquisition Strategy

What this section provides: This section converts market intelligence into actionable recommendations for growth planning, technology positioning, surgeon adoption, hospital contracting, channel expansion, investment decisions and competitive differentiation.

14. U.S. Orthopedic Reconstruction Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Market Sizing and Estimation Limitation
14.5. Legal Disclaimer
14.6. Third-Party Data Disclaimer
14.7. Company and Product Information Disclaimer
14.8. Regulatory and Reimbursement Information Disclaimer

What this section provides: This section clarifies the report’s scope limitations, legal boundaries, data-use terms, market-estimation methodology and forecasting assumptions.

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Orthopedic Reconstruction Devices Market: Market Definition and Scope
TABLE 3: U.S. Orthopedic Reconstruction Devices Market: Research Methodology Framework
TABLE 4: U.S. Orthopedic Reconstruction Devices Market: Key Assumptions
TABLE 5: U.S. Orthopedic Reconstruction Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Orthopedic Reconstruction Devices Market: Stakeholder Analysis
TABLE 7: U.S. Orthopedic Reconstruction Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Orthopedic Reconstruction Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Orthopedic Reconstruction Devices Market: Market Attractiveness Index
TABLE 10: U.S. Orthopedic Reconstruction Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Orthopedic Reconstruction Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Orthopedic Reconstruction Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Orthopedic Reconstruction Devices Market: Drivers; Impact Analysis
TABLE 14: U.S. Orthopedic Reconstruction Devices Market: Restraints; Impact Analysis
TABLE 15: U.S. Orthopedic Reconstruction Devices Market: Opportunities; Impact Analysis
TABLE 16: U.S. Orthopedic Reconstruction Devices Market: Challenges; Impact Analysis
TABLE 17: U.S. Orthopedic Reconstruction Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 18: U.S. Orthopedic Reconstruction Devices Market: Joint Replacement Procedure Volume Analysis
TABLE 19: U.S. Orthopedic Reconstruction Devices Market: Clinical Workflow Economics Matrix
TABLE 20: U.S. Orthopedic Reconstruction Devices Market: Hospital Capital Procurement Behavior Matrix
TABLE 21: U.S. Orthopedic Reconstruction Devices Market: Ambulatory Joint Replacement Economics Matrix
TABLE 22: U.S. Orthopedic Reconstruction Devices Market: Implant Pricing and Total Episode Cost Matrix
TABLE 23: U.S. Orthopedic Reconstruction Devices Market: PESTEL Analysis
TABLE 24: U.S. Orthopedic Reconstruction Devices Market: Porter’s Five Forces Analysis
TABLE 25: U.S. Orthopedic Reconstruction Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 26: U.S. Orthopedic Reconstruction Devices Market: Implant Pricing Analysis by Joint Category
TABLE 27: U.S. Orthopedic Reconstruction Devices Market: Value Chain Analysis
TABLE 28: U.S. Orthopedic Reconstruction Devices Market: Supply Chain Analysis
TABLE 29: U.S. Orthopedic Reconstruction Devices Market: Raw Material and Orthopedic Component Supply Analysis
TABLE 30: U.S. Orthopedic Reconstruction Devices Market: Digitalization and Connected Orthopedic Care Impact
TABLE 31: U.S. Orthopedic Reconstruction Devices Market: Application & Innovation Landscape
TABLE 32: U.S. Orthopedic Reconstruction Devices Market: Orthopedic Registry and Real-World Evidence Landscape
TABLE 33: U.S. Orthopedic Reconstruction Devices Market: FDA Regulatory Framework Analysis
TABLE 34: U.S. Orthopedic Reconstruction Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 35: U.S. Orthopedic Reconstruction Devices Market: Bundled-Payment and Episode-Based Care Analysis
TABLE 36: U.S. Orthopedic Reconstruction Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 37: U.S. Orthopedic Reconstruction Devices Market: Government Initiatives and Musculoskeletal Health Programs
TABLE 38: U.S. Orthopedic Reconstruction Devices Market: Impact of Escalating Geopolitical Tensions
TABLE 39: U.S. Orthopedic Reconstruction Devices Market: Hospital Value Analysis Committee Decision Framework
TABLE 40: U.S. Orthopedic Reconstruction Devices Market: Ambulatory Surgery Center Vendor Selection Framework
TABLE 41: U.S. Orthopedic Reconstruction Devices Market: Sustainability, Reprocessing and Operating-Room Waste Considerations
TABLE 42: U.S. Orthopedic Reconstruction Devices Market: Product Type Snapshot, 2025
TABLE 43: Segment Dashboard; Definition and Scope, by Product Type
TABLE 44: U.S. Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 45: U.S. Orthopedic Reconstruction Devices Market: Segment Share Analysis, by Product Type, 2025 & 2035 (%)
TABLE 46: U.S. Orthopedic Reconstruction Devices Market: Knee Reconstruction Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: U.S. Orthopedic Reconstruction Devices Market: Hip Reconstruction Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: U.S. Orthopedic Reconstruction Devices Market: Shoulder Reconstruction Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Orthopedic Reconstruction Devices Market: Foot and Ankle Reconstruction Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. Orthopedic Reconstruction Devices Market: Elbow and Small-Joint Reconstruction Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Orthopedic Reconstruction Devices Market: Clinical Application Snapshot, 2025
TABLE 52: Segment Dashboard; Definition and Scope, by Clinical Application
TABLE 53: U.S. Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 54: U.S. Orthopedic Reconstruction Devices Market: Segment Share Analysis, by Clinical Application, 2025 & 2035 (%)
TABLE 55: U.S. Orthopedic Reconstruction Devices Market: Osteoarthritis and Degenerative Joint Disease Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Orthopedic Reconstruction Devices Market: Rheumatoid and Inflammatory Arthritis Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Orthopedic Reconstruction Devices Market: Trauma and Post-Traumatic Joint Reconstruction Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. Orthopedic Reconstruction Devices Market: Osteonecrosis, Deformity and Congenital Joint Conditions Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. Orthopedic Reconstruction Devices Market: Revision Arthroplasty and Implant Failure Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: U.S. Orthopedic Reconstruction Devices Market: End User Snapshot, 2025
TABLE 61: Segment Dashboard; Definition and Scope, by End User
TABLE 62: U.S. Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 63: U.S. Orthopedic Reconstruction Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 64: U.S. Orthopedic Reconstruction Devices Market: Hospitals and Integrated Delivery Networks Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Orthopedic Reconstruction Devices Market: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Orthopedic Reconstruction Devices Market: Orthopedic Specialty Hospitals and Dedicated Joint Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Orthopedic Reconstruction Devices Market: Academic Medical Centers and Regional Referral Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. Orthopedic Reconstruction Devices Market: Orthopedic Clinics and Other Outpatient Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: U.S. Orthopedic Reconstruction Devices Market: Technology Type Snapshot, 2025
TABLE 70: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 71: U.S. Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 72: U.S. Orthopedic Reconstruction Devices Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 73: U.S. Orthopedic Reconstruction Devices Market: Conventional Manual Implant Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Orthopedic Reconstruction Devices Market: Robotic-Assisted Reconstruction Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Orthopedic Reconstruction Devices Market: Navigation and Digital Planning Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Orthopedic Reconstruction Devices Market: Patient-Specific and Additively Manufactured Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Orthopedic Reconstruction Devices Market: Smart Implants and Connected Recovery Platforms Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: U.S. Orthopedic Reconstruction Devices Market: Procurement Channel Snapshot, 2025
TABLE 79: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 80: U.S. Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 81: U.S. Orthopedic Reconstruction Devices Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 82: U.S. Orthopedic Reconstruction Devices Market: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: U.S. Orthopedic Reconstruction Devices Market: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: U.S. Orthopedic Reconstruction Devices Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 85: U.S. Orthopedic Reconstruction Devices Market: Distributor and Specialty Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 86: U.S. Orthopedic Reconstruction Devices Market: Ambulatory and Physician-Owned Facility Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 87: U.S. Orthopedic Reconstruction Devices Market: Regional Snapshot, 2025
TABLE 88: Segment Dashboard; Definition and Scope, by Region
TABLE 89: U.S. Orthopedic Reconstruction Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 90: U.S. Orthopedic Reconstruction Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 91: West Region U.S. Orthopedic Reconstruction Devices Market: Regional Overview and Trends
TABLE 92: West Region U.S. Orthopedic Reconstruction Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 93: West Region U.S. Orthopedic Reconstruction Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 94: West Region U.S. Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 95: West Region U.S. Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 96: West Region U.S. Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 97: West Region U.S. Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 98: West Region U.S. Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 99: California Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 100: California Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 101: California Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 102: California Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 103: California Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 104: Washington Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 105: Washington Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 106: Washington Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 107: Washington Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 108: Washington Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 109: Arizona Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 110: Arizona Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 111: Arizona Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 112: Arizona Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 113: Arizona Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 114: Colorado Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 115: Colorado Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 116: Colorado Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 117: Colorado Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 118: Colorado Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 119: Oregon Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 120: Oregon Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 121: Oregon Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 122: Oregon Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 123: Oregon Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 124: Utah Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 125: Utah Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 126: Utah Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 127: Utah Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 128: Utah Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 129: Nevada Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 130: Nevada Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 131: Nevada Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 132: Nevada Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 133: Nevada Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 134: New Mexico Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 135: New Mexico Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 136: New Mexico Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 137: New Mexico Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 138: New Mexico Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 139: Idaho Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 140: Idaho Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 141: Idaho Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 142: Idaho Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 143: Idaho Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 144: Montana Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 145: Montana Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 146: Montana Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 147: Montana Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 148: Montana Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 149: Wyoming Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 150: Wyoming Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 151: Wyoming Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 152: Wyoming Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 153: Wyoming Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 154: Alaska Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 155: Alaska Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 156: Alaska Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 157: Alaska Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 158: Alaska Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 159: Hawaii Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 160: Hawaii Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 161: Hawaii Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 162: Hawaii Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 163: Hawaii Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 164: Northeast Region U.S. Orthopedic Reconstruction Devices Market: Regional Overview and Trends
TABLE 165: Northeast Region U.S. Orthopedic Reconstruction Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 166: Northeast Region U.S. Orthopedic Reconstruction Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 167: Northeast Region U.S. Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 168: Northeast Region U.S. Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 169: Northeast Region U.S. Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 170: Northeast Region U.S. Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 171: Northeast Region U.S. Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 172: New York Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 173: New York Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 174: New York Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 175: New York Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 176: New York Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 177: Massachusetts Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 178: Massachusetts Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 179: Massachusetts Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 180: Massachusetts Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 181: Massachusetts Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 182: New Jersey Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 183: New Jersey Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 184: New Jersey Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 185: New Jersey Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 186: New Jersey Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 187: Pennsylvania Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 188: Pennsylvania Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 189: Pennsylvania Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 190: Pennsylvania Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 191: Pennsylvania Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 192: Connecticut Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 193: Connecticut Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 194: Connecticut Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 195: Connecticut Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 196: Connecticut Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 197: Maine Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 198: Maine Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 199: Maine Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 200: Maine Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 201: Maine Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 202: Vermont Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 203: Vermont Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 204: Vermont Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 205: Vermont Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 206: Vermont Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 207: New Hampshire Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 208: New Hampshire Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 209: New Hampshire Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 210: New Hampshire Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 211: New Hampshire Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 212: Rhode Island Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 213: Rhode Island Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 214: Rhode Island Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 215: Rhode Island Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 216: Rhode Island Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 217: Delaware Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 218: Delaware Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 219: Delaware Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 220: Delaware Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 221: Delaware Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 222: South Region U.S. Orthopedic Reconstruction Devices Market: Regional Overview and Trends
TABLE 223: South Region U.S. Orthopedic Reconstruction Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 224: South Region U.S. Orthopedic Reconstruction Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 225: South Region U.S. Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 226: South Region U.S. Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 227: South Region U.S. Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 228: South Region U.S. Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 229: South Region U.S. Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 230: Texas Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 231: Texas Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 232: Texas Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 233: Texas Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 234: Texas Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 235: Florida Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 236: Florida Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 237: Florida Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 238: Florida Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 239: Florida Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 240: Georgia Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 241: Georgia Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 242: Georgia Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 243: Georgia Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 244: Georgia Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 245: North Carolina Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 246: North Carolina Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 247: North Carolina Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 248: North Carolina Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 249: North Carolina Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 250: Tennessee Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 251: Tennessee Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 252: Tennessee Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 253: Tennessee Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 254: Tennessee Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 255: South Carolina Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 256: South Carolina Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 257: South Carolina Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 258: South Carolina Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 259: South Carolina Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 260: Alabama Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 261: Alabama Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 262: Alabama Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 263: Alabama Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 264: Alabama Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 265: Mississippi Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 266: Mississippi Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 267: Mississippi Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 268: Mississippi Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 269: Mississippi Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 270: Louisiana Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 271: Louisiana Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 272: Louisiana Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 273: Louisiana Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 274: Louisiana Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 275: Arkansas Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 276: Arkansas Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 277: Arkansas Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 278: Arkansas Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 279: Arkansas Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 280: Kentucky Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 281: Kentucky Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 282: Kentucky Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 283: Kentucky Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 284: Kentucky Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 285: Oklahoma Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 286: Oklahoma Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 287: Oklahoma Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 288: Oklahoma Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 289: Oklahoma Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 290: Virginia Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 291: Virginia Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 292: Virginia Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 293: Virginia Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 294: Virginia Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 295: Maryland Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 296: Maryland Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 297: Maryland Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 298: Maryland Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 299: Maryland Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 300: West Virginia Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 301: West Virginia Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 302: West Virginia Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 303: West Virginia Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 304: West Virginia Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 305: Midwest Region U.S. Orthopedic Reconstruction Devices Market: Regional Overview and Trends
TABLE 306: Midwest Region U.S. Orthopedic Reconstruction Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 307: Midwest Region U.S. Orthopedic Reconstruction Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 308: Midwest Region U.S. Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 309: Midwest Region U.S. Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 310: Midwest Region U.S. Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 311: Midwest Region U.S. Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 312: Midwest Region U.S. Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 313: Illinois Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 314: Illinois Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 315: Illinois Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 316: Illinois Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 317: Illinois Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 318: Ohio Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 319: Ohio Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 320: Ohio Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 321: Ohio Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 322: Ohio Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 323: Michigan Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 324: Michigan Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 325: Michigan Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 326: Michigan Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 327: Michigan Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 328: Minnesota Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 329: Minnesota Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 330: Minnesota Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 331: Minnesota Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 332: Minnesota Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 333: Indiana Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 334: Indiana Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 335: Indiana Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 336: Indiana Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 337: Indiana Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 338: Wisconsin Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 339: Wisconsin Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 340: Wisconsin Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 341: Wisconsin Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 342: Wisconsin Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 343: Missouri Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 344: Missouri Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 345: Missouri Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 346: Missouri Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 347: Missouri Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 348: Iowa Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 349: Iowa Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 350: Iowa Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 351: Iowa Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 352: Iowa Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 353: Kansas Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 354: Kansas Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 355: Kansas Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 356: Kansas Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 357: Kansas Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 358: Nebraska Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 359: Nebraska Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 360: Nebraska Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 361: Nebraska Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 362: Nebraska Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 363: North Dakota Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 364: North Dakota Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 365: North Dakota Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 366: North Dakota Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 367: North Dakota Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 368: South Dakota Orthopedic Reconstruction Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 369: South Dakota Orthopedic Reconstruction Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 370: South Dakota Orthopedic Reconstruction Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 371: South Dakota Orthopedic Reconstruction Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 372: South Dakota Orthopedic Reconstruction Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 373: U.S. Orthopedic Reconstruction Devices Market: Competitive Landscape Snapshot, 2025
TABLE 374: U.S. Orthopedic Reconstruction Devices Market: Key Company Market Share Analysis, 2025
TABLE 375: U.S. Orthopedic Reconstruction Devices Market: Company Positioning Matrix
TABLE 376: U.S. Orthopedic Reconstruction Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 377: U.S. Orthopedic Reconstruction Devices Market: Robotic and Digital Capabilities Benchmarking
TABLE 378: U.S. Orthopedic Reconstruction Devices Market: U.S. Distribution and Surgeon Support Benchmarking
TABLE 379: U.S. Orthopedic Reconstruction Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 380: Stryker Corporation: Company Profile
TABLE 381: Zimmer Biomet Holdings, Inc.: Company Profile
TABLE 382: DePuy Synthes – Johnson & Johnson MedTech: Company Profile
TABLE 383: Smith+Nephew plc: Company Profile
TABLE 384: Enovis Corporation: Company Profile
TABLE 385: Exactech, Inc.: Company Profile
TABLE 386: Globus Medical, Inc.: Company Profile
TABLE 387: Arthrex, Inc.: Company Profile
TABLE 388: Medacta International: Company Profile
TABLE 389: MicroPort Orthopedics: Company Profile
TABLE 390: Corin Group: Company Profile
TABLE 391: B. Braun Aesculap: Company Profile
TABLE 392: restor3d, Inc.: Company Profile
TABLE 393: Shoulder Innovations, Inc.: Company Profile
TABLE 394: Catalyst OrthoScience Inc.: Company Profile
TABLE 395: THINK Surgical, Inc.: Company Profile
TABLE 396: OrthAlign, Inc.: Company Profile
TABLE 397: Materialise NV: Company Profile
TABLE 398: United Orthopedic Corporation: Company Profile
TABLE 399: Ortho Development Corporation: Company Profile
TABLE 400: Waldemar LINK GmbH & Co. KG: Company Profile
TABLE 401: Maxx Orthopedics, Inc.: Company Profile
TABLE 402: Implantcast GmbH: Company Profile
TABLE 403: Tyber Medical LLC: Company Profile
TABLE 404: U.S. Orthopedic Reconstruction Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 405: U.S. Orthopedic Reconstruction Devices Market: Disruptive Technologies Impact Matrix
TABLE 406: U.S. Orthopedic Reconstruction Devices Market: Emerging Business Trends
TABLE 407: U.S. Orthopedic Reconstruction Devices Market: Business Opportunities for Startups and Existing Players
TABLE 408: U.S. Orthopedic Reconstruction Devices Market: Investment Prioritization Matrix
TABLE 409: U.S. Orthopedic Reconstruction Devices Market: Product-Technology Opportunity Matrix
TABLE 410: U.S. Orthopedic Reconstruction Devices Market: Regional Expansion Opportunity Matrix
TABLE 411: U.S. Orthopedic Reconstruction Devices Market: Market Entry and Partnership Opportunity Assessment
TABLE 412: U.S. Orthopedic Reconstruction Devices Market: Strategic Recommendations for Orthopedic Implant Manufacturers
TABLE 413: U.S. Orthopedic Reconstruction Devices Market: Strategic Recommendations for Robotic and Digital Surgery Companies
TABLE 414: U.S. Orthopedic Reconstruction Devices Market: Strategic Recommendations for Hospitals and Integrated Delivery Networks
TABLE 415: U.S. Orthopedic Reconstruction Devices Market: Strategic Recommendations for Orthopedic Specialty Hospitals and Joint Centers
TABLE 416: U.S. Orthopedic Reconstruction Devices Market: Strategic Recommendations for Ambulatory Surgery Centers
TABLE 417: U.S. Orthopedic Reconstruction Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 418: U.S. Orthopedic Reconstruction Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 419: U.S. Orthopedic Reconstruction Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 420: U.S. Orthopedic Reconstruction Devices Market: Go-to-Market Strategy Considerations
TABLE 421: U.S. Orthopedic Reconstruction Devices Market: Surgeon Education and Conversion Strategy
TABLE 422: U.S. Orthopedic Reconstruction Devices Market: Hospital Value Analysis and Economic Evidence Strategy
TABLE 423: U.S. Orthopedic Reconstruction Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 424: U.S. Orthopedic Reconstruction Devices Market: ASC-Specific Commercialization Strategy
TABLE 425: U.S. Orthopedic Reconstruction Devices Market: Regional and State-Level Market Expansion Strategy
TABLE 426: U.S. Orthopedic Reconstruction Devices Market: Partnership, Licensing and Acquisition Strategy
TABLE 427: U.S. Orthopedic Reconstruction Devices Market: Scope Limitation
TABLE 428: U.S. Orthopedic Reconstruction Devices Market: Data Use Limitation
TABLE 429: U.S. Orthopedic Reconstruction Devices Market: Forecasting Limitation
TABLE 430: U.S. Orthopedic Reconstruction Devices Market: Market Sizing and Estimation Limitation
TABLE 431: U.S. Orthopedic Reconstruction Devices Market: Legal Disclaimer
TABLE 432: U.S. Orthopedic Reconstruction Devices Market: Third-Party Data Disclaimer
TABLE 433: U.S. Orthopedic Reconstruction Devices Market: Company and Product Information Disclaimer
TABLE 434: U.S. Orthopedic Reconstruction Devices Market: Regulatory and Reimbursement Information Disclaimer

List of Figures

FIGURE 1: U.S. Orthopedic Reconstruction Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: Supply Chain Analysis
FIGURE 5: PESTEL Analysis
FIGURE 6: Porter’s Five Forces Analysis
FIGURE 7: Market Attractiveness Analysis
FIGURE 8: Market Dynamics
FIGURE 9: Innovation & Patent Landscape, 2021–2025
FIGURE 10: Joint Replacement Procedure Volume Analysis
FIGURE 11: Clinical Workflow Economics Framework
FIGURE 12: Hospital Capital Procurement Decision Framework
FIGURE 13: Ambulatory Joint Replacement Economics Framework
FIGURE 14: Implant Pricing and Total Episode Cost Framework
FIGURE 15: U.S. Orthopedic Reconstruction Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 16: U.S. Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 17: U.S. Orthopedic Reconstruction Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 18: Product Type Segment Market Share Analysis, 2025 & 2035
FIGURE 19: Product Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Knee Reconstruction Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Hip Reconstruction Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Shoulder Reconstruction Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Foot and Ankle Reconstruction Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Elbow and Small-Joint Reconstruction Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Clinical Application Segment Market Share Analysis, 2025 & 2035
FIGURE 26: Clinical Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Osteoarthritis and Degenerative Joint Disease Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Rheumatoid and Inflammatory Arthritis Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Trauma and Post-Traumatic Joint Reconstruction Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Osteonecrosis, Deformity and Congenital Joint Conditions Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Revision Arthroplasty and Implant Failure Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 33: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Hospitals and Integrated Delivery Networks Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Ambulatory Surgery Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Orthopedic Specialty Hospitals and Dedicated Joint Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Academic Medical Centers and Regional Referral Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Orthopedic Clinics and Other Outpatient Providers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 40: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Conventional Manual Implant Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Robotic-Assisted Reconstruction Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Navigation and Digital Planning Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Patient-Specific and Additively Manufactured Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Smart Implants and Connected Recovery Platforms Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 47: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Direct Hospital and Health System Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Distributor and Specialty Supplier Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Ambulatory and Physician-Owned Facility Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 54: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: West Region U.S. Orthopedic Reconstruction Devices Market Share and Leading Players, 2025
FIGURE 56: West Region Market Share Analysis by State, 2025
FIGURE 57: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: California Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: Washington Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Arizona Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Colorado Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: Oregon Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Utah Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Nevada Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: New Mexico Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Idaho Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Montana Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Wyoming Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Alaska Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Hawaii Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Northeast Region U.S. Orthopedic Reconstruction Devices Market Share and Leading Players, 2025
FIGURE 72: Northeast Region Market Share Analysis by State, 2025
FIGURE 73: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: New York Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Massachusetts Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: New Jersey Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Pennsylvania Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Connecticut Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Maine Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Vermont Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: New Hampshire Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: Rhode Island Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: Delaware Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: South Region U.S. Orthopedic Reconstruction Devices Market Share and Leading Players, 2025
FIGURE 85: South Region Market Share Analysis by State, 2025
FIGURE 86: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: Texas Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Florida Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Georgia Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: North Carolina Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Tennessee Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: South Carolina Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Alabama Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Mississippi Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Louisiana Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Arkansas Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Kentucky Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Oklahoma Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Virginia Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Maryland Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: West Virginia Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Midwest Region U.S. Orthopedic Reconstruction Devices Market Share and Leading Players, 2025
FIGURE 103: Midwest Region Market Share Analysis by State, 2025
FIGURE 104: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Illinois Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Ohio Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Michigan Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Minnesota Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Indiana Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Wisconsin Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Missouri Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Iowa Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Kansas Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Nebraska Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: North Dakota Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: South Dakota Orthopedic Reconstruction Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 118: Company Positioning Matrix
FIGURE 119: Key Player Product Portfolio Benchmarking
FIGURE 120: Robotic and Digital Capabilities Benchmarking
FIGURE 121: U.S. Distribution and Surgeon Support Benchmarking
FIGURE 122: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 123: Orthopedic Reconstruction Device Innovation Roadmap
FIGURE 124: Robotic-Assisted Joint Reconstruction Adoption Roadmap
FIGURE 125: Cementless Implant Technology Opportunity Map
FIGURE 126: Patient-Specific and 3D-Printed Implant Growth Roadmap
FIGURE 127: Smart Implant and Connected Recovery Opportunity Map
FIGURE 128: Future Market Scenario Analysis, 2026–2035
FIGURE 129: Disruptive Technologies Impact Matrix
FIGURE 130: Emerging Business Trends Matrix
FIGURE 131: Investment Prioritization Matrix
FIGURE 132: Product-Technology Opportunity Matrix
FIGURE 133: Regional Expansion Opportunity Matrix
FIGURE 134: Strategic Growth Roadmap for U.S. Orthopedic Reconstruction Device Companies
FIGURE 135: Go-to-Market Strategy Framework
FIGURE 136: Product Positioning and Portfolio Expansion Framework
FIGURE 137: Report Scope and Disclaimer Framework